{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T01:10:37Z","timestamp":1768698637417,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,10,6]],"date-time":"2010-10-06T00:00:00Z","timestamp":1286323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s00228-010-0906-2","type":"journal-article","created":{"date-parts":[[2010,10,5]],"date-time":"2010-10-05T13:26:29Z","timestamp":1286285189000},"page":"1189-1197","source":"Crossref","is-referenced-by-count":12,"title":["Systemic uptake of miconazole during vaginal suppository use and effect on CYP1A2 and CYP3A4 associated enzyme activities in women"],"prefix":"10.1007","volume":"66","author":[{"given":"Mia Birkh\u00f8j","family":"Kj\u00e6rstad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flemming","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lene","family":"N\u00f8hr-Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stine","family":"Zwisler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Br\u00f8sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helle Raun","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,6]]},"reference":[{"key":"906_CR1","first-page":"165","volume":"6","author":"J Boelaert","year":"1976","unstructured":"Boelaert J, Daneels R, Van Landuyt H, Symoens J (1976) Miconazole plasma levels in healthy subjects and in patients with impaired renal function. Chemotherapy 6:165\u2013169","journal-title":"Chemotherapy"},{"key":"906_CR2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00003088-198308010-00002","volume":"8","author":"TK Daneshmend","year":"1983","unstructured":"Daneshmend TK, Warnock DW (1983) Clinical pharmacokinetics of systemic antifungal drugs. Clin Pharmacokinet 8:17\u201342","journal-title":"Clin Pharmacokinet"},{"key":"906_CR3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/jac\/18.4.507","volume":"18","author":"TK Daneshmend","year":"1986","unstructured":"Daneshmend TK (1986) Systemic absorption of miconazole from the vagina. J Antimicrob Chemother 18:507\u2013511","journal-title":"J Antimicrob Chemother"},{"key":"906_CR4","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/AAC.21.5.730","volume":"21","author":"PT Mannisto","year":"1982","unstructured":"Mannisto PT, Mantyla R, Nykanen S, Lamminsivu U, Ottoila P (1982) Impairing effect of food on ketoconazole absorption. Antimicrob Agents Chemother 21:730\u2013733","journal-title":"Antimicrob Agents Chemother"},{"key":"906_CR5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0002-9343(76)90428-9","volume":"60","author":"DA Stevens","year":"1976","unstructured":"Stevens DA, Levine HB, Deresinski SC (1976) Miconazole in coccidioidomycosis. II. Therapeutic and pharmacologic studies in man. Am J Med 60:191\u2013202","journal-title":"Am J Med"},{"key":"906_CR6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1381-1169(00)00437-4","volume":"165","author":"M Murty","year":"2001","unstructured":"Murty M (2001) Miconazole-warfarin interaction: increased INR. CMAJ 165:81\u201386","journal-title":"CMAJ"},{"key":"906_CR7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/sj.bdj.4811224","volume":"196","author":"MN Pemberton","year":"2004","unstructured":"Pemberton MN, Oliver RJ, Theaker ED (2004) Miconazole oral gel and drug interactions. Br Dent J 196:529\u2013531","journal-title":"Br Dent J"},{"key":"906_CR8","author":"MB Kjaerstad","year":"2010","unstructured":"Kjaerstad MB, Taxvig C, Nellemann C, Vinggaard AM, Andersen HR (2010) Endocrine disrupting effects in vitro of conazole antifungals used as pesticides and pharmaceuticals. Reprod Toxicol. doi: 10.1016\/j.reprotox.2010.07.009","journal-title":"Reprod Toxicol"},{"key":"906_CR9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0022-4731(87)90511-5","volume":"28","author":"M Ayub","year":"1987","unstructured":"Ayub M, Levell MJ (1987) Inhibition of testicular 17 alpha-hydroxylase and 17, 20-lyase but not 3 beta-hydroxysteroid dehydrogenase-isomerase or 17 beta-hydroxysteroid oxidoreductase by ketoconazole and other imidazole drugs. J Steroid Biochem 28:521\u2013531","journal-title":"J Steroid Biochem"},{"key":"906_CR10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0022-4731(89)90384-1","volume":"32","author":"M Ayub","year":"1989","unstructured":"Ayub M, Levell MJ (1989) Inhibition of human adrenal steroidogenic enzymes in vitro by imidazole drugs including ketoconazole. J Steroid Biochem 32:515\u2013524","journal-title":"J Steroid Biochem"},{"key":"906_CR11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0039-128X(83)90070-3","volume":"50","author":"JI Mason","year":"1987","unstructured":"Mason JI, Carr BR, Murry BA (1987) Imidazole antimycotics: selective inhibitors of steroid aromatization and progesterone hydroxylation. Steroids 50:179\u2013189","journal-title":"Steroids"},{"key":"906_CR12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tox.2005.10.020","volume":"219","author":"ER Trosken","year":"2006","unstructured":"Trosken ER, Fischer K, Volkel W, Lutz WK (2006) Inhibition of human CYP19 by azoles used as antifungal agents and aromatase inhibitors, using a new LC-MS\/MS method for the analysis of estradiol product formation. Toxicology 219:33\u201340","journal-title":"Toxicology"},{"key":"906_CR13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tox.2006.08.007","volume":"228","author":"ER Trosken","year":"2006","unstructured":"Trosken ER, Adamska M, Arand M et al (2006) Comparison of lanosterol-14 alpha-demethylase (CYP51) of human and Candida albicans for inhibition by different antifungal azoles. Toxicology 228:24\u201332","journal-title":"Toxicology"},{"key":"906_CR14","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/dmd.30.3.314","volume":"30","author":"W Zhang","year":"2002","unstructured":"Zhang W, Ramamoorthy Y, Kilicarslan T et al (2002) Inhibition of cytochromes P450 by antifungal imidazole derivatives. Drug Metab Dispos 30:314\u2013318","journal-title":"Drug Metab Dispos"},{"key":"906_CR15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/carcin\/18.1.207","volume":"18","author":"M Shou","year":"1997","unstructured":"Shou M, Korzekwa KR, Brooks EN et al (1997) Role of human hepatic cytochrome P450 1A2 and 3A4 in the metabolic activation of estrone. Carcinogenesis 18:207\u2013214","journal-title":"Carcinogenesis"},{"key":"906_CR16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1021\/tx970217f","volume":"11","author":"H Yamazaki","year":"1998","unstructured":"Yamazaki H, Shaw PM, Guengerich FP, Shimada T (1998) Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Chem Res Toxicol 11:659\u2013665","journal-title":"Chem Res Toxicol"},{"key":"906_CR17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1742-7843.2007.00114.x","volume":"102","author":"P Grandjean","year":"2008","unstructured":"Grandjean P, Bellinger D, Bergman A et al (2008) The Faroes statement: human health effects of developmental exposure to chemicals in our environment. Basic Clin Pharmacol Toxicol 102:73\u201375","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"906_CR18","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/humrep\/16.5.972","volume":"16","author":"NE Skakkebaek","year":"2001","unstructured":"Skakkebaek NE, Rajpert-De Meyts E, Main KM (2001) Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 16:972\u2013978","journal-title":"Hum Reprod"},{"key":"906_CR19","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1289\/ehp.8100","volume":"113","author":"SH Swan","year":"2005","unstructured":"Swan SH, Main KM, Liu F et al (2005) Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect 113:1056\u20131061","journal-title":"Environ Health Perspect"},{"key":"906_CR20","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/toxsci\/kfm227","volume":"100","author":"C Taxvig","year":"2007","unstructured":"Taxvig C, Hass U, Axelstad M et al (2007) Endocrine-disrupting activities in vivo of the fungicides tebuconazole and epoxiconazole. Toxicol Sci 100:464\u2013473","journal-title":"Toxicol Sci"},{"key":"906_CR21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2605.2005.00604.x","volume":"29","author":"AM Vinggaard","year":"2006","unstructured":"Vinggaard AM, Hass U, Dalgaard M et al (2006) Prochloraz: an imidazole fungicide with multiple mechanisms of action. Int J Androl 29:186\u2013192","journal-title":"Int J Androl"},{"key":"906_CR22","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0009-9236(03)00050-X","volume":"73","author":"M Christensen","year":"2003","unstructured":"Christensen M, Andersson K, Dalen P et al (2003) The Karolinska cocktail for phenotyping of five human cytochrome P450 enzymes. Clin Pharmacol Ther 73:517\u2013528","journal-title":"Clin Pharmacol Ther"},{"key":"906_CR23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1067\/mcp.2000.108532","volume":"68","author":"P Damkier","year":"2000","unstructured":"Damkier P, Brosen K (2000) Quinidine as a probe for CYP3A4 activity: intrasubject variability and lack of correlation with probe-based assays for CYP1A2, CYP2C9, CYP2C19, and CYP2D6. Clin Pharmacol Ther 68:199\u2013209","journal-title":"Clin Pharmacol Ther"},{"key":"906_CR24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0009-9236(97)90114-4","volume":"62","author":"RF Frye","year":"1997","unstructured":"Frye RF, Matzke GR, Adedoyin A, Porter JA, Branch RA (1997) Validation of the five-drug \u201cPittsburgh cocktail\u201d approach for assessment of selective regulation of drug-metabolising enzymes. Clin Pharmacol Ther 62:365\u2013376","journal-title":"Clin Pharmacol Ther"},{"key":"906_CR25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/clpt.1994.49","volume":"55","author":"KL Rost","year":"1994","unstructured":"Rost KL, Roots I (1994) Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: coincidence with plasma clearance and breath test. Clin Pharmacol Ther 55:402\u2013411","journal-title":"Clin Pharmacol Ther"},{"key":"906_CR26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00007691-199606000-00006","volume":"18","author":"BB Rasmussen","year":"1996","unstructured":"Rasmussen BB, Brosen K (1996) Determination of urinary metabolites of caffeine for the assessment of cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activity in humans. Ther Drug Monit 18:254\u2013262","journal-title":"Ther Drug Monit"},{"key":"906_CR27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0378-4347(94)00259-2","volume":"660","author":"F Nielsen","year":"1994","unstructured":"Nielsen F, Nielsen KK, Brosen K (1994) Determination of quinidine, dihydroquinidine, (3S)-3-hydroxyquinidine and quinidine N-oxide in plasma and urine by high-performance liquid chromatography. J Chromatogr B Biomed Appl 660:103\u2013110","journal-title":"J Chromatogr B Biomed Appl"},{"key":"906_CR28","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00403-005-0555-y","volume":"296","author":"JB Nielsen","year":"2005","unstructured":"Nielsen JB (2005) Percutaneous penetration through slightly damaged skin. Arch Dermatol Res 296:560\u2013567","journal-title":"Arch Dermatol Res"},{"key":"906_CR29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1124\/mol.105.022046","volume":"70","author":"C Duret","year":"2006","unstructured":"Duret C, Daujat-Chavanieu M, Pascussi JM et al (2006) Ketoconazole and miconazole are antagonists of the human glucocorticoid receptor: consequences on the expression and function of the constitutive androstane receptor and the pregnane X receptor. Mol Pharmacol 70:329\u2013339","journal-title":"Mol Pharmacol"},{"key":"906_CR30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00008571-200208000-00008","volume":"12","author":"BB Rasmussen","year":"2002","unstructured":"Rasmussen BB, Brix TH, Kyvik KO, Brosen K (2002) The interindividual differences in the 3-demethylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors. Pharmacogenetics 12:473\u2013478","journal-title":"Pharmacogenetics"},{"key":"906_CR31","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00228-006-0205-0","volume":"62","author":"MS Petersen","year":"2006","unstructured":"Petersen MS, Halling J, Damkier P et al (2006) Caffeine N3-demethylation (CYP1A2) in a population with an increased exposure to polychlorinated biphenyls. Eur J Clin Pharmacol 62:1041\u20131048","journal-title":"Eur J Clin Pharmacol"},{"key":"906_CR32","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0009-9236(98)90105-9","volume":"63","author":"AD Kashuba","year":"1998","unstructured":"Kashuba AD, Bertino JS Jr, Kearns GL et al (1998) Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotyping. Clin Pharmacol Ther 63:540\u2013551","journal-title":"Clin Pharmacol Ther"},{"key":"906_CR33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00000542-199707000-00005","volume":"87","author":"ED Kharasch","year":"1997","unstructured":"Kharasch ED, Russell M, Garton K et al (1997) Assessment of cytochrome P450 3A4 activity during the menstrual cycle using alfentanil as a noninvasive probe. Anesthesiology 87:26\u201335","journal-title":"Anesthesiology"},{"key":"906_CR34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5414\/CPP38235","volume":"38","author":"M Zaigler","year":"2000","unstructured":"Zaigler M, Rietbrock S, Szymanski J et al (2000) Variation of CYP1A2-dependent caffeine metabolism during menstrual cycle in healthy women. Int J Clin Pharmacol Ther 38:235\u2013244","journal-title":"Int J Clin Pharmacol Ther"},{"key":"906_CR35","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.taap.2007.07.002","volume":"224","author":"MS Petersen","year":"2007","unstructured":"Petersen MS, Halling J, Damkier P et al (2007) Polychlorinated biphenyl (PCB) induction of CYP3A4 enzyme activity in healthy Faroese adults. Toxicol Appl Pharmacol 224:202\u2013206","journal-title":"Toxicol Appl Pharmacol"},{"key":"906_CR36","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1124\/dmd.106.012351","volume":"34","author":"C Chang","year":"2006","unstructured":"Chang C, Bahadduri PM, Polli JE, Swaan PW, Ekins S (2006) Rapid identification of P-glycoprotein substrates and inhibitors. Drug Metab Dispos 34:1976\u20131984","journal-title":"Drug Metab Dispos"},{"key":"906_CR37","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1080\/00498250802050880","volume":"38","author":"R Elsby","year":"2008","unstructured":"Elsby R, Surry DD, Smith VN, Gray AJ (2008) Validation and application of Caco-2 assays for the in vitro evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions. Xenobiotica 38:1140\u20131164","journal-title":"Xenobiotica"},{"key":"906_CR38","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/01.CIR.99.4.552","volume":"99","author":"MF Fromm","year":"1999","unstructured":"Fromm MF, Kim RB, Stein CM, Wilkinson GR, Roden DM (1999) Inhibition of P-glycoprotein-mediated drug transport: a unifying mechanism to explain the interaction between digoxin and quinidine [see comments]. Circulation 99:552\u2013557","journal-title":"Circulation"},{"key":"906_CR39","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1211\/0022357056118","volume":"57","author":"T Sakaeda","year":"2005","unstructured":"Sakaeda T, Iwaki K, Kakumoto M et al (2005) Effect of micafungin on cytochrome P450 3A4 and multidrug resistance protein 1 activities, and its comparison with azole antifungal drugs. J Pharm Pharmacol 57:759\u2013764","journal-title":"J Pharm Pharmacol"},{"key":"906_CR40","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1476-5381.2009.00336.x","volume":"158","author":"K Vahakangas","year":"2009","unstructured":"Vahakangas K, Myllynen P (2009) Drug transporters in the human blood-placental barrier. Br J Pharmacol 158:665\u2013678","journal-title":"Br J Pharmacol"},{"key":"906_CR41","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1248\/bpb.28.1805","volume":"28","author":"T Niwa","year":"2005","unstructured":"Niwa T, Shiraga T, Takagi A (2005) Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes. Biol Pharm Bull 28:1805\u20131808","journal-title":"Biol Pharm Bull"},{"key":"906_CR42","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1248\/bpb.28.1813","volume":"28","author":"T Niwa","year":"2005","unstructured":"Niwa T, Inoue-Yamamoto S, Shiraga T, Takagi A (2005) Effect of antifungal drugs on cytochrome P450 (CYP) 1A2, CYP2D6, and CYP2E1 activities in human liver microsomes. Biol Pharm Bull 28:1813\u20131816","journal-title":"Biol Pharm Bull"},{"key":"906_CR43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/bmj.314.7077.349a","volume":"314","author":"S Ariyaratnam","year":"1997","unstructured":"Ariyaratnam S, Thakker NS, Sloan P, Thornhill MH (1997) Potentiation of warfarin anticoagulant activity by miconazole oral gel. BMJ 314:349","journal-title":"BMJ"},{"key":"906_CR44","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/clpt.1992.78","volume":"51","author":"RA O'Reilly","year":"1992","unstructured":"O'Reilly RA, Goulart DA, Kunze KL et al (1992) Mechanisms of the stereoselective interaction between miconazole and racemic warfarin in human subjects. Clin Pharmacol Ther 51:656\u2013667","journal-title":"Clin Pharmacol Ther"},{"key":"906_CR45","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1055\/s-0037-1613916","volume":"83","author":"M Silingardi","year":"2000","unstructured":"Silingardi M, Ghirarduzzi A, Tincani E, Iorio A, Iori I (2000) Miconazole oral gel potentiates warfarin anticoagulant activity. Thromb Haemost 83:794\u2013795","journal-title":"Thromb Haemost"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-010-0906-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-010-0906-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-010-0906-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T23:17:22Z","timestamp":1711840642000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-010-0906-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,6]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["906"],"URL":"https:\/\/doi.org\/10.1007\/s00228-010-0906-2","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,6]]}}}